The animal health industry continues to face challenges of new and emerging diseases as well as improvements in current commercial vaccines. Here are 5 things Mike Roof wants you to know about mRNA vaccines.
Launching the new Center on Vaccine Evaluation and Alternatives for Antimicrobials, or CVEAA, Kansas State University’s College of Veterinary Medicine aims to support animal vaccine development and usage.
According to Iowa State University's David Verhoeven, vaccines using mRNA technology have been shown to reduce disease on farms, and it’s all but impossible for them to end up in your food.
Misinformation and conspiracy theories regarding the use of mRNA vaccines in livestock continue, despite efforts of the scientific community, who emphasize, "mRNA from a vaccine will NOT be passed along in meat."
Household units and mini fridges are often unsuitable for maintaining veterinary products, according to a recent study by Emmanuel Rollin, DVM, College of Veterinary Medicine at the University of Georgia.
United Animal Health, Johnsonville Ventures and the Iowa Corn Growers Association commit support to Genvax Technologies, a startup dedicated to advancing self-amplifying mRNA vaccine production in animal health.
APHIS will invest $27.1 million in foot-and-mouth disease (FMD) vaccine the Agency can use in the event of an outbreak to protect animals and help stop the spread of disease.
A U.S. government watchdog’s latest report says America’s swine and cattle populations are vulnerable to the highly contagious, deadly foot-and-mouth disease (FMD).
A U.S. government watchdog’s latest report says America’s swine and cattle populations are vulnerable to the highly contagious, deadly foot-and-mouth disease (FMD).
The USDA’s Center for Veterinary Biologics (CVB) recently issued CVB Notice 18-05 Detection of Senecavirus A (SVA) in Veterinary Biological Products to warn of potential contamination of swine vaccines.
New research studies the potential for new swine flu strains to emerge globally and their connection to the human population. It also looks at whether one global swine flu vaccine could be a solution.
AgriLabs has entered the vaccine manufacturing business with a new facility in Lincoln, Neb. It, along with other acquisitions, opens worldwide opportunities, the company says.
Minnesota producers are considering a new PRRS/PED proposal that will help them learn more about both diseases. It would be a voluntary program in cooperation with the Minnesota Board of Animal Health.
As one of the researchers who helped developed pigs resistant to the Porcine Reproductive and Respiratory Syndrome (PRRS) virus said, "At the very least, the development of PRRS-resistant pigs is a new tool for im